1-55058666-CGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT-CGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_174936.4(PCSK9):​c.1503+70_1503+71delGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,502,512 control chromosomes in the GnomAD database, including 122 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 62 hom., cov: 0)
Exomes 𝑓: 0.015 ( 60 hom. )

Consequence

PCSK9
NM_174936.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.18

Publications

1 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant 1-55058666-CGT-C is Benign according to our data. Variant chr1-55058666-CGT-C is described in ClinVar as Benign. ClinVar VariationId is 928569.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 62 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.1503+70_1503+71delGT
intron
N/ANP_777596.2
PCSK9
NM_001407240.1
c.1626+70_1626+71delGT
intron
N/ANP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.1503+70_1503+71delGT
intron
N/ANP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.1503+20_1503+21delGT
intron
N/AENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.1860+20_1860+21delGT
intron
N/AENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.1626+20_1626+21delGT
intron
N/AENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.0294
AC:
4173
AN:
142008
Hom.:
62
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0256
Gnomad AMI
AF:
0.0102
Gnomad AMR
AF:
0.0271
Gnomad ASJ
AF:
0.0355
Gnomad EAS
AF:
0.00189
Gnomad SAS
AF:
0.0133
Gnomad FIN
AF:
0.0154
Gnomad MID
AF:
0.0405
Gnomad NFE
AF:
0.0371
Gnomad OTH
AF:
0.0273
GnomAD2 exomes
AF:
0.0127
AC:
1901
AN:
149146
AF XY:
0.0121
show subpopulations
Gnomad AFR exome
AF:
0.0213
Gnomad AMR exome
AF:
0.0160
Gnomad ASJ exome
AF:
0.0153
Gnomad EAS exome
AF:
0.00162
Gnomad FIN exome
AF:
0.00392
Gnomad NFE exome
AF:
0.0158
Gnomad OTH exome
AF:
0.0180
GnomAD4 exome
AF:
0.0148
AC:
20128
AN:
1360424
Hom.:
60
AF XY:
0.0150
AC XY:
10143
AN XY:
674716
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0160
AC:
495
AN:
30890
American (AMR)
AF:
0.0134
AC:
522
AN:
38834
Ashkenazi Jewish (ASJ)
AF:
0.0214
AC:
520
AN:
24316
East Asian (EAS)
AF:
0.00497
AC:
183
AN:
36834
South Asian (SAS)
AF:
0.0109
AC:
873
AN:
79954
European-Finnish (FIN)
AF:
0.0153
AC:
721
AN:
47266
Middle Eastern (MID)
AF:
0.0127
AC:
50
AN:
3952
European-Non Finnish (NFE)
AF:
0.0151
AC:
15733
AN:
1042144
Other (OTH)
AF:
0.0183
AC:
1031
AN:
56234
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.318
Heterozygous variant carriers
0
1548
3096
4644
6192
7740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0294
AC:
4179
AN:
142088
Hom.:
62
Cov.:
0
AF XY:
0.0277
AC XY:
1910
AN XY:
68838
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0256
AC:
968
AN:
37784
American (AMR)
AF:
0.0271
AC:
395
AN:
14556
Ashkenazi Jewish (ASJ)
AF:
0.0355
AC:
119
AN:
3352
East Asian (EAS)
AF:
0.00190
AC:
9
AN:
4740
South Asian (SAS)
AF:
0.0140
AC:
61
AN:
4362
European-Finnish (FIN)
AF:
0.0154
AC:
141
AN:
9134
Middle Eastern (MID)
AF:
0.0331
AC:
9
AN:
272
European-Non Finnish (NFE)
AF:
0.0371
AC:
2415
AN:
65052
Other (OTH)
AF:
0.0271
AC:
53
AN:
1956
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.395
Heterozygous variant carriers
0
157
314
471
628
785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0217
Hom.:
1122

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hypercholesterolemia, autosomal dominant, 3 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35115360; hg19: chr1-55524339; API